Pictet North America Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $883K | Hold |
6,875
| – | – | 0.08% | 106 |
|
|
2026
Q1 | $827K | Hold |
6,875
| – | – | 0.08% | 101 |
|
|
2025
Q4 | $724K | Hold |
6,875
| – | – | 0.07% | 104 |
|
|
2025
Q3 | $577K | Hold |
6,875
| – | – | 0.05% | 106 |
|
|
2025
Q2 | $544K | Hold |
6,875
| – | – | 0.05% | 107 |
|
|
2025
Q1 | $617K | Sell |
6,875
-654
| -9% | -$61.1K | 0.06% | 100 |
|
|
2024
Q4 | $749K | Hold |
7,529
| – | – | 0.07% | 104 |
|
|
2024
Q3 | $855K | Buy |
7,529
+154
| +2% | +$18.3K | 0.08% | 98 |
|
|
2024
Q2 | $913K | Hold |
7,375
| – | – | 0.1% | 97 |
|
|
2024
Q1 | $973K | Hold |
7,375
| – | – | 0.11% | 95 |
|
|
2023
Q4 | $804K | Hold |
7,375
| – | – | 0.1% | 89 |
|
|
2023
Q3 | $759K | Sell |
7,375
-300
| -4% | -$32.3K | 0.11% | 92 |
|
|
2023
Q2 | $886K | Hold |
7,675
| – | – | 0.12% | 85 |
|
|
2023
Q1 | $817K | Hold |
7,675
| – | – | 0.13% | 82 |
|
|
2022
Q4 | $852K | Hold |
7,675
| – | – | 0.15% | 76 |
|
|
2022
Q3 | $661K | Buy |
7,675
+300
| +4% | +$26.8K | 0.11% | 89 |
|
|
2022
Q2 | $672K | Hold |
7,375
| – | – | 0.09% | 95 |
|
|
2022
Q1 | $605K | Sell |
7,375
-652
| -8% | -$51.4K | 0.07% | 96 |
|
|
2021
Q4 | $615K | Hold |
8,027
| – | – | 0.06% | 94 |
|
|
2021
Q3 | $603K | Hold |
8,027
| – | – | 0.06% | 94 |
|
|
2021
Q2 | $624K | Buy |
8,027
+139
| +2% | +$10.3K | 0.06% | 94 |
|
|
2021
Q1 | $580K | Hold |
7,888
| – | – | 0.07% | 93 |
|
|
2020
Q4 | $616K | Buy |
7,888
+160
| +2% | +$12.2K | 0.08% | 96 |
|
|
2020
Q3 | $612K | Buy |
7,728
+313
| +4% | +$24.5K | 0.09% | 91 |
|
|
2020
Q2 | $547K | Hold |
7,415
| – | – | 0.08% | 98 |
|
|
2020
Q1 | $544K | Sell |
7,415
-511
| -6% | -$40.2K | 0.09% | 100 |
|
|
2019
Q4 | $688K | Sell |
7,926
-327
| -4% | -$26.9K | 0.08% | 101 |
|
|
2019
Q3 | $663K | Hold |
8,253
| – | – | 0.09% | 100 |
|
|
2019
Q2 | $660K | Sell |
8,253
-2,747
| -25% | -$210K | 0.1% | 99 |
|
|
2019
Q1 | $873K | Buy |
11,000
+43
| +0.4% | +$3.22K | 0.13% | 88 |
|
|
2018
Q4 | $799K | Hold |
10,957
| – | – | 0.07% | 96 |
|
|
2018
Q3 | $742K | Buy |
+10,957
| New | +$698K | 0.1% | 100 |
|
|
2018
Q1 | – | Sell |
-39,552
| Closed | -$2.12M | – | 140 |
|
|
2017
Q4 | $2.12M | Buy |
39,552
+8,788
| +29% | +$487K | 0.33% | 51 |
|
|
2017
Q3 | $1.88M | Sell |
30,764
-2,253
| -7% | -$137K | 0.3% | 58 |
|
|
2017
Q2 | $2.02M | Sell |
33,017
-1,127
| -3% | -$68.6K | 0.34% | 53 |
|
|
2017
Q1 | $2.07M | Buy |
34,144
+2,856
| +9% | +$173K | 0.35% | 51 |
|
|
2016
Q4 | $1.76M | Sell |
31,288
-11,566
| -27% | -$677K | 0.39% | 52 |
|
|
2016
Q3 | $2.55M | Buy |
42,854
+566
| +1% | +$33.1K | 0.61% | 27 |
|
|
2016
Q2 | $2.33M | Sell |
42,288
-297
| -0.7% | -$15.8K | 0.54% | 30 |
|
|
2016
Q1 | $2.15M | Buy |
42,585
+9,117
| +27% | +$447K | 0.45% | 31 |
|
|
2015
Q4 | $1.69M | Buy |
33,468
+5,045
| +18% | +$254K | 0.39% | 29 |
|
|
2015
Q3 | $1.34M | Buy |
+28,423
| New | +$1.51M | 0.37% | 24 |
|
|
2015
Q2 | – | Sell |
-31,420
| Closed | -$1.72M | – | 72 |
|
|
2015
Q1 | $1.72M | Sell |
31,420
-419
| -1% | -$23.7K | 0.33% | 26 |
|
|
2014
Q4 | $1.73M | Buy |
31,839
+23,134
| +266% | +$1.29M | 0.35% | 27 |
|
|
2014
Q3 | $492K | Buy |
8,705
+1,468
| +20% | +$82.4K | 0.12% | 35 |
|
|
2014
Q2 | $400K | Sell |
7,237
-8,149
| -53% | -$445K | 0.1% | 27 |
|
|
2014
Q1 | $833K | Buy |
15,386
+4,612
| +43% | +$239K | 0.23% | 29 |
|
|
2013
Q4 | $515K | Buy |
+10,774
| New | +$492K | 0.12% | 40 |
|
Other funds holding MRK
ECSS
Pictet North America Advisors's MRK Position: Q2 2026 in Review
Pictet North America Advisors held its Merck (MRK) position steady in Q2 2026 at 6,875 shares worth $883K. The position accounts for 0.08% of the portfolio, ranked #106.
Pictet North America Advisors first reported a position in MRK in Q4 2013 and has held it in 48 quarters since. The position peaked at $2.55M in Q3 2016. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Pictet North America Advisors held 6,875 shares of Merck worth $883K as of Q2 2026.
- Pictet North America Advisors left its Merck share count unchanged in Q2 2026.
- Merck made up 0.08% of Pictet North America Advisors's portfolio in Q2 2026, its #106 holding.
- Pictet North America Advisors first reported a position in Merck in Q4 2013 and has held it in 48 quarters since.
- Pictet North America Advisors's Merck position peaked at $2.55M in Q3 2016.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.